Multiple Sclerosis News Today Forums › Forums › Trials and Research › Phase 3 Trial of Oral Therapy Amantadine is Recruiting MS Patients

  • Trials and Research

    Phase 3 Trial of Oral Therapy Amantadine is Recruiting MS Patients

    Posted by MS News Today Moderator on April 10, 2019 at 11:02 am

    A Phase 3 trial testing ADS-5102 (amantadine) in all MS types is enrolling participants to determine whether the oral therapy can improve walking speed. Click here to learn more.

    What are your thoughts on this news? Do you feel optimistic about this therapy’s potential to treat MS?

    replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .